If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

Filter
Article

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy

Herrstedt, J., Roila, F., Warr, D., Celio, L., Navari, R. M., Hesketh, P. J., Chan, A. & Aapro, M. S., Jan 1 2017, In : Supportive Care in Cancer. 25, 1, p. 277-288 12 p.

Research output: Contribution to journalArticle

Emetics
aprepitant
Nausea
Vomiting
Cyclophosphamide

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial

Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., Fowst, C., Arkhipov, A., Salle, E. D., Polli, A. & Massimini, G., Jun 2000, In : Journal of Clinical Oncology. 18, 11, p. 2234-2244 11 p.

Research output: Contribution to journalArticle

exemestane
Aromatase Inhibitors
Breast Neoplasms
Confidence Intervals
Aromatase

Acute confusional state with fatal outcome in a cancer patient

Caraceni, A., Andreola, S., Simonetti, F. & Celio, L., Feb 2004, In : Neurological Sciences. 24, 6, p. 424-425 2 p.

Research output: Contribution to journalArticle

Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: Long-term results of an experience at the Milan Cancer Institute

Salvadori, B., Celio, L., Oriana, R. & Bajetta, E., May 2000, In : Tumori. 86, 3, p. 258-259 2 p.

Research output: Contribution to journalArticle

Open Access
Biliary Tract Neoplasms
Circulating Neoplastic Cells
Biopsy
Therapeutics
Survival

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

Bajetta, E., Celio, L., Ferrario, E., Di Bartolomeo, M., Denaro, A., Dotti, K., Mancin, M., Bajetta, R., Colombo, A. & Pusceddu, S., Nov 2007, In : Annals of Oncology. 18, 11, p. 1810-1816 7 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Colorectal Neoplasms
Therapeutics
Metastasectomy

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E. & Bombardieri, E., Sep 1 1999, In : Cancer. 86, 5, p. 858-865 8 p.

Research output: Contribution to journalArticle

Chromogranin A
Neuroendocrine Tumors
Phosphopyruvate Hydratase
Carcinoembryonic Antigen
Acetic Acid

Clinical and endocrine effects of megestrol acetate in women with pretreated advanced breast cancer

Vicario, G., Celio, L., Bajetta, E., Zampino, M. G., Longhi, A., Buzzoni, R., Botti, C., Bogni, A., Bombardieri, E., Rimassa, L. & Laffranchi, A., 1995, In : Oncology Reports. 2, 1, p. 63-68 6 p.

Research output: Contribution to journalArticle

Megestrol Acetate
Breast Neoplasms
Appointments and Schedules
Progestins
Therapeutics

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting

Celio, L., Denaro, A., Canova, S., Gevorgyan, A. & Bajetta, E., Jul 2008, In : Tumori. 94, 4, p. 447-452 6 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Drug Therapy
Dexamethasone
Serotonin Antagonists

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: A multicentre study by the ITMO group

Buzzoni, R., Biganzoli, L., Bajetta, E., Celio, L., Fornasiero, A., Mariani, L., Zilembo, N., Di Bartolomeo, M., Di Leo, A., Arcangeli, G., Aitini, E., Farina, G., Schieppati, G., Galluzzo, D. & Martinetti, A., 1995, In : British Journal of Cancer. 71, 5, p. 1111-1114 4 p.

Research output: Contribution to journalArticle

Goserelin
Medical Oncology
Tamoxifen
Multicenter Studies
Breast Neoplasms

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy

Restelli, U., Saibene, G., Nardulli, P., DI Turi, R., Bonizzoni, E., Scolari, F., Perrone, T., Croce, D. & Celio, L., Jul 1 2017, In : BMJ Open. 7, 7, e015645.

Research output: Contribution to journalArticle

Budgets
Nausea
Italy
Vomiting
fosaprepitant

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari, L., Bajetta, E., Martinetti, A., Celio, L., Longarini, R., La Torre, I., Buzzoni, R., Gattinoni, L., Seregni, E. & Bombardieri, E., May 2003, In : International Journal of Oncology. 22, 5, p. 1081-1089 9 p.

Research output: Contribution to journalArticle

exemestane
letrozole
Aminoglutethimide
Aromatase Inhibitors
Somatomedins

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

Bajetta, E., Zilembo, N., Dowsett, M., Guillevin, L., Di Leo, A., Celio, L., Martinetti, A., Marchianò, A., Pozzi, P., Stani, S. & Bichisao, E., Feb 1999, In : European Journal of Cancer. 35, 2, p. 208-213 6 p.

Research output: Contribution to journalArticle

letrozole
Multicenter Studies
Breast Neoplasms
Thyroxine
Sex Hormone-Binding Globulin

Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer

Ferrari, L., Zilembo, N., Bajetta, E., Buzzoni, R., Noberasco, C., Martinetti, A., Celio, L., Galante, E., Orefice, S. & Cerrotta, A. M., Jan 1994, In : Breast Cancer Research and Treatment. 30, 2, p. 127-132 6 p.

Research output: Contribution to journalArticle

Insulin-Like Growth Factor I
Breast Neoplasms
Serum
Aminoglutethimide
Aromatase Inhibitors

Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer

Ferrari, L., Bajetta, E., Seregni, E., Martinetti, A., Zilembo, N., Noberasco, C., Buzzoni, R., Botti, C., Massaron, S., Bichisao, E., Celio, L. & Bombardieri, E., 1997, In : International Journal of Oncology. 11, 1, p. 163-167 5 p.

Research output: Contribution to journalArticle

Insulin-Like Growth Factor Binding Protein 3
Aromatase
Somatomedins
Breast Neoplasms
Aromatase Inhibitors

Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: An immunocytochemical study

Bajetta, E., Celio, L., Di Leo, A., Bartoli, C., Pilotti, S., Leutner, M., Bono, A., Ferrari, L., Buzzoni, R., Zilembo, N., De Candis, D. & Moglia, D., Apr 1998, In : International Journal of Oncology. 12, 4, p. 853-858 6 p.

Research output: Contribution to journalArticle

Steroid Receptors
Tamoxifen
Fine Needle Biopsy
Breast Neoplasms
Ki-67 Antigen

Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy

Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Celio, L. & Bichisao, E., 1993, In : Cancer Treatment Reviews. 19, SUPPL. B, p. 31-36 6 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Aromatase Inhibitors
Therapeutics
Neoplasm Metastasis
Drug Therapy

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Bajetta, E., Ferrari, L., Procopio, G., Catena, L., Ferrario, E., Martinetti, A., Di Bartolomeo, M., Buzzoni, R., Celio, L., Vitali, M., Beretta, E., Seregni, E. & Bombardieri, E., 2002, In : Annals of Oncology. 13, 4, p. 614-621 8 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Combination Drug Therapy
Neoplasms
Therapeutics
Epirubicin

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer

Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Di Leo, A., Bartoli, C., Merson, M., Sacchini, V., Moglia, D., Cefo, L. & Nelli, P., Jul 1994, In : British Journal of Cancer. 70, 1, p. 145-150 6 p.

Research output: Contribution to journalArticle

Breast Neoplasms
17-Hydroxycorticosteroids
Aromatase
Serum
Estrogen Receptors

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy

Mirabile, A., Celio, L., Magni, M., Bonizzoni, E., Gianni, A. M. & Di Nicola, M., Dec 1 2014, In : Future Oncology. 10, 16, p. 2569-2578 10 p.

Research output: Contribution to journalArticle

Vomiting
Appointments and Schedules
Antiemetics
Drug Therapy
Dexamethasone

Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

Di Renzo, N., Melillo, L., Porretto, F., Dargenio, M., Pavone, V., Pastore, D., Mazza, P., Mannina, D., Merenda, A., Cascavilla, N., Greco, G., Matera, R., Bonizzoni, E., Celio, L. & Musso, M., Jan 1 2019, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Open Access
aprepitant
Induction Chemotherapy
Acute Myeloid Leukemia
Vomiting
Drug Therapy

Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer

Bajetta, E., Verzoni, E., Ferrario, E., Dotti, K., Gevorgyan, A. & Celio, L., Jan 2009, In : Tumori. 95, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Feasibility Studies
Stomach Neoplasms
Capecitabine

Fluoropyrimidines in the treatment of advanced neoplastic diseases: Role and advantages of UFT

Del Vecchio, M., Procopio, G., Cassata, A., Pozzi, P., Busto, G., Celio, L. & Bajetta, E., Jan 1999, In : Tumori. 85, 1, p. 6-11 6 p.

Research output: Contribution to journalArticle

Fluorouracil
Uracil
Colorectal Neoplasms
Tegafur
Antimetabolites

Formestane as treatment of advanced breast cancer in elderly women

Zilembo, N., Buzzoni, R., Celio, L., Noberasco, C., Ferrari, L., Laffranchi, A., Vicario, G., Dolci, S. & Bajetta, E., 1994, In : Tumori. 80, 6, p. 433-437 5 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Viscera
formestane
Drug Therapy

Goserelin in premenopausal advanced breast cancer: Clinical and endocrine evaluation of responsive patients

Bajetta, E., Zilembo, N., Buzzoni, R., Celio, L., Zampino, M. G., Colleoni, M., Oriana, S., Attili, A., Sacchini, V. & Martinetti, E. A., 1994, In : Oncology. 51, 3, p. 262-269 8 p.

Research output: Contribution to journalArticle

Goserelin
Ovariectomy
Breast Neoplasms
Follicle Stimulating Hormone
Serum

Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: A meta-analysis of randomised evidence

Celio, L., Bonizzoni, E., Zattarin, E., Codega, P., De Braud, F. & Aapro, M., Dec 30 2019, In : BMC Cancer. 19, 1, 1268.

Research output: Contribution to journalArticle

Open Access
Nausea
Dexamethasone
Meta-Analysis
Drug Therapy
Vomiting

Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial

Damian, S., Celio, L., De Benedictis, E., Mariani, P., Agustoni, F., Ricchini, F. & De Braud, F., Jun 2013, In : Oncology. 84, 6, p. 371-377 7 p.

Research output: Contribution to journalArticle

Paclitaxel
Doxorubicin
Dexamethasone
Vomiting
Breast Neoplasms

Neuroendocrine tumors of the larynx: A clinical report and literature review

Procopio, G., Ricotta, R., Fusi, A., Celio, L., De Dosso, S., Catena, L., Ferrari, L., Quattrone, P., Verzoni, E. & Bajetta, E., Jan 2006, In : Tumori. 92, 1, p. 72-75 4 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Larynx
Neoplasms
Incidence
Therapeutics

New clinical trials for the treatment of neuroendocrine tumors

Bajetta, E., Bichisao, E., Artale, S., Celio, L., Ferrari, L., Di Bartolomeo, M., Zilembo, N., Stani, S. C. & Buzzoni, R., 2000, In : Quarterly Journal of Nuclear Medicine. 44, 1, p. 96-101 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Clinical Trials
Octreotide
Carcinoid Tumor
Therapeutics

Novel non-steroidal aromatase inhibitors: Are there new perspectives in the treatment of breast cancer?

Bajetta, E., Celio, L., Buzzoni, R. & Bichisao, E., Sep 1996, In : Tumori. 82, 5, p. 417-422 6 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Aminoglutethimide
letrozole
Breast Neoplasms
vorozole

Ovarian ablation for premenopausal early-stage breast cancer: An update

Celio, L., Bajetta, E., Toffolatti, L., Catena, L., Beretta, E. & Buzzoni, R., May 2000, In : Tumori. 86, 3, p. 191-194 4 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Castration
Ovariectomy
Gonadotropin-Releasing Hormone
Estrogens

Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer

Bajetta, E., Celio, L., Zilembo, N., Bono, A., Galluzzo, D., Zampino, M. G., Longhi, A., Ferrari, L. & Buzzoni, R., 1994, In : Tumori. 80, 1, p. 28-32 5 p.

Research output: Contribution to journalArticle

Goserelin
Gonadotropin-Releasing Hormone
Castration
Breast Neoplasms
Drug Compounding

Palonosetron: An evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Celio, L., Agustoni, F., Testa, I., Dotti, K. & De Braud, F., May 2012, In : Tumori. 98, 3, p. 279-286 8 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Drug Therapy
Dexamethasone
Serotonin Receptors

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: A randomized, multicenter, phase III trial

Celio, L., Frustaci, S., Denaro, A., Buonadonna, A., Ardizzoia, A., Piazza, E., Fabi, A., Capobianco, A. M., Isa, L., Cavanna, L., Bertolini, A., Bichisao, E. & Bajetta, E., Aug 2011, In : Supportive Care in Cancer. 19, 8, p. 1217-1225 9 p.

Research output: Contribution to journalArticle

Nausea
Dexamethasone
Vomiting
Drug Therapy
Cyclophosphamide

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: An evidence-based review of safety, efficacy, and place in therapy

Celio, L., Niger, M., Ricchini, F. & Agustoni, F., Aug 21 2015, In : Core Evidence. 10, p. 75-87 13 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Safety
Drug Therapy
Receptors, Serotonin, 5-HT3
Nausea
Dexamethasone
Vomiting
Drug Therapy
Antiemetics

Palonosetron plus dexamethasone in highly emetogenic chemotherapy: Pooled data from two Phase III trials

Celio, L., Agustoni, F., Ricchini, F., Dotti, K., Niger, M. & Braud, F. D., Oct 2013, In : Future Oncology. 9, 10, p. 1451-1458 8 p.

Research output: Contribution to journalArticle

Dexamethasone
Drug Therapy
Nausea
Vomiting
Granisetron
Anthracyclines
Cyclophosphamide
Nausea
Dexamethasone
Vomiting

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer

Cappelletti, V., Gariboldi, M., De Cecco, L., Toffanin, S., Reid, J. F., Lusa, L., Bajetta, E., Celio, L., Greco, M., Fabbri, A., Pierotti, M. A. & Daidone, M. G., Jun 2008, In : Endocrine-Related Cancer. 15, 2, p. 439-449 11 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Estrogens
Breast Neoplasms
Gene Expression
Therapeutics

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: A multi-institutional phase II study

Celio, L., Sternberg, C. N., Labianca, R., La Torre, I., Amoroso, V., Barone, C., Pinotti, G., Cascinu, S., Di Costanzo, F., Cetto, G. L. & Bajetta, E., 2009, In : Annals of Oncology. 20, 6, p. 1062-1067 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Pemetrexed
Stomach Neoplasms
Confidence Intervals
Therapeutics

Pemetrexed in gastric cancer: Clinical experience and future perspectives

Celio, L., Buzzoni, R., Longarini, R., Marchianò, A. & Bajetta, E., Dec 2002, In : Seminars in Oncology. 29, 6 SUPPL. 18, p. 63-68 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Stomach Neoplasms
Folic Acid
Folic Acid Antagonists
Esophagogastric Junction

Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer

Bajetta, E., Celio, L., Buzzoni, R., Ferrari, L., Marchianò, A., Martinetti, A., Longarini, R., Becerra, C., Ilardi, C. & John, W., Oct 2003, In : Annals of Oncology. 14, 10, p. 1543-1548 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Folic Acid
Stomach Neoplasms
Neutropenia

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease

Bajetta, E., Di Leo, A., Biganzoli, L., Mariani, L., Cappuzzo, F., Di Bartolomeo, M., Zilembo, N., Artale, S., Magnani, E., Celio, L., Buzzoni, R. & Carnaghi, C., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2546-2551 6 p.

Research output: Contribution to journalArticle

Platinum
Ovarian Neoplasms
Neutropenia
Anemia
Confidence Intervals

Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity

Correale, P., Procopio, A., Celio, L., Caraglia, M., Genua, G., Coppola, V., Pepe, S., Normanno, N., Vecchio, I., Palmieri, G., Montagnani, S., Tagliaferri, P. & Bianco, A. R., Jul 1992, In : Cancer Immunology, Immunotherapy. 34, 4, p. 272-278 7 p.

Research output: Contribution to journalArticle

Lymphokines
Natural Killer Cells
Melanoma
Acetates
Integrin alphaVbeta3
Dacarbazine
Interferons
Cisplatin
Glutathione
Melanoma
Aromatase Inhibitors
Gonadotropin-Releasing Hormone
Breast Neoplasms
Triptorelin Pamoate
Estrogens

Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: The experience of the National Cancer Institute of Milan

Colleoni, M., Bajetta, E., Nelli, P., Boni, L., Bochicchio, A. M., Nole, F., Buzzoni, R., Celio, L., Mazzaferro, V., Bonfanti, G., Bignami, P. & Gennari, L., 1993, In : Annals of Oncology. 4, 6, p. 489-493 5 p.

Research output: Contribution to journalArticle

Prognostic Factors
Chemotherapy
National Cancer Institute (U.S.)
Hepatocellular Carcinoma
Cancer

Pro-netupitant/palonosetron (IV) for the treatment of radio-and-chemotherapy-induced nausea and vomiting

Celio, L. & Fabbroni, C., Aug 2018, In : Expert Opinion on Pharmacotherapy. 19, 11, p. 1267-1277 11 p.

Research output: Contribution to journalArticle

Radio
Nausea
Vomiting
Antiemetics
Drug Therapy

Prospective evaluation of estrogen receptor-β in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients

Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M. & Daidone, M. G., Dec 2004, In : Endocrine-Related Cancer. 11, 4, p. 761-770 10 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Estrogen Receptor Modulators
Estrogen Receptors
Breast Neoplasms
Messenger RNA